Search Login Register

Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight) Summary

Description: Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of hemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism.

Also Known As: Heparin, Low Molecular Weight; Heparin, Low-Molecular-Weight; Low Molecular Weight Heparin; LMWH

Networked: 4313 relevant articles (562 outcomes, 985 trials/studies) for this Bio-Agent

Key Diseases for which Low-Molecular-Weight Heparin is Relevant

  1. Venous Thrombosis (Deep-Vein Thrombosis) : 105 outcomes 193 studies in 815 results
  2. Venous Thromboembolism : 95 outcomes 148 studies in 646 results
  3. Neoplasms (Cancer) : 79 outcomes 147 studies in 449 results
  4. Hemorrhage : 75 outcomes 134 studies in 762 results
  5. Thrombosis (Thrombus) : 65 outcomes 97 studies in 636 results
Show All >>

Drugs Related to Low-Molecular-Weight Heparin

  1. Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
  2. Heparin (Liquaemin)
  3. Enoxaparin (Lovenox)
  4. Dalteparin (Dalteparin Sodium)
  5. Warfarin (Coumadin)
  6. Aspirin (Acetylsalicylic Acid)
  7. fondaparinux (Arixtra)
  8. Vitamin K
  9. tinzaparin (Innohep)
  10. Anticoagulants
Show All >>

Therapies Related to Low-Molecular-Weight Heparin

  1. Renal Dialysis (Hemodialysis)
  2. Arthroplasty
  3. Hip Replacement Arthroplasty (Total Hip Replacement)
  4. Compression Stockings
  5. Vitrectomy
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.